Evidence map›Paper›PMID 40306593›Full record

ArticleJournal of vascular surgery2025

Increased market competition is associated with lower mortality after complex aortic surgery.

Zach M Feldman, Gregory Leya, Andrew Oseran, Xinyan Zheng, Jialin Mao, Brandon J Sumpio, Sunita D Srivastava, Philip P Goodney, Mark F Conrad, Abhisekh Mohapatra

Abstract read
In one paragraph

Article in Journal of vascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zach M FeldmanDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: zmfeldman@mgh.harvard.edu.
Gregory LeyaDepartment of Surgery, Massachusetts General Hospital, Boston, MA.
Andrew OseranDivision of Cardiovascular Medicine, Massachusetts General Hospital, Boston, MA.
Xinyan ZhengDepartment of Population Health Sciences, Weill Cornell Medical College, New York, NY.
Jialin MaoDepartment of Population Health Sciences, Weill Cornell Medical College, New York, NY.
Brandon J SumpioDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.
Sunita D SrivastavaDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.
Philip P GoodneyDivision of Vascular and Endovascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Mark F ConradSteward Center for Vascular and Endovascular Surgery, St. Elizabeth's Medical Center, Boston, MA.
Abhisekh MohapatraDivision of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.

Funding

Leveraging linked registry and electronic health records to examine long-term patient outcomes after peripheral vascular intervention"K01HL159315 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MAO, JIALIN · 2021 to 2025
$810k
NHLBI NIH HHS K01 HL159315
6 · The paper itself

Abstract

objectiveCentralized aortic hubs frequently exist in competitive markets, which have at times demonstrated inferior surgical outcomes. Here we evaluate the impact of local market competition specifically on complex aortic surgical outcomes.

methodsA retrospective review included all Vascular Quality Initiative (VQI) patients between 2013 and 2022 undergoing index complex endovascular aortic repair, thoracic endovascular aortic repair, or open aortic repair. Market competition was defined by the Herfindahl-Hirschman index (HHI), using surgeon-level market share within blinded VQI regions or metropolitan statistical areas (MSAs). A higher HHI indicates lower competition. Multivariable logistic 30-day mortality models and Cox survival models were used to examine the association between HHI and outcomes. A sensitivity analysis further adjusted for complexity among all complex and routine aortic surgical patients in the Vascular Implant Surveillance and Interventional Outcomes Network from 2017 to 2019, using generalized estimating equations with MSA-level clustering.

resultsThe VQI contained 10,868 complex aortic surgical patients, with 4372 additional patients in MSA-based Vascular Implant Surveillance and Interventional Outcomes Network sensitivity analysis. The median patient age was 75 years. Of these patients, 68.4% were male, with a greater number of patients in high competition regions (51.3%) and MSAs (34.6%) vs medium and low competition locales. Comorbidities and aneurysm diameter were broadly similar across HHI intervals. Lower 30-day mortality was observed in high competition regions (high, 23.7%; medium, 25.9%; low, 25.9%; P = .03). In multivariable logistic models, medium regional competition was associated with greater 30-day mortality odds vs high competition (odds ratio [OR], 1.39; 95% CI, 1.21-1.60; P < .001), with a trend toward increased mortality for low competition (OR, 1.20; 95% CI, 0.98-1.45; P = .07). MSA-based sensitivity analyses demonstrated a similar trend for medium competition MSAs (OR, 1.25; 95% CI, 0.98-1.58; P = .07), without significant relationship for low-competition MSAs. Regional interval was not associated with any long-term mortality difference.

conclusionsMore competitive regions demonstrate lower 30-day mortality after complex aortic surgery but equivalent long-term survival. Further efforts should focus on drivers of this difference to widen access to high-quality complex aortic care.

Indexed as

Aortic DiseasesBlood Vessel Prosthesis ImplantationEconomic CompetitionEndovascular ProceduresAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUnited StatesAbdominal aorticAneurysmDissection, arterialEndovascular interventionsSocial determinants of healthThoracic/thoracoabdominal

Identifiers

PMID40306593
PMCPMC12353547

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.